10/19/2026
Louisiana is taking a closer look at how pharmacy benefits are managed, and employers should be paying attention.
Through Acts 474 and 913, the state has expanded regulation of Pharmacy Benefit Managers (PBMs), introducing new requirements around manufacturer rebates, transparency, pharmacy reimbursement, dispensing fees, spread pricing, and patient steering. Together, the changes are designed to bring greater oversight to the way prescription drug benefits are administered.
For employers sponsoring group health plans, these reforms could have implications for prescription drug costs, PBM contracts, pharmacy networks, plan pricing, and future renewals. Act 913’s provisions surrounding retroactive claim reprocessing may also create additional financial considerations for employers and carriers.
With certain provisions taking effect at different times and questions remaining around how some requirements may apply to self-funded ERISA plans, staying informed will be especially important.
At The Competitive Advantage Companies, we help employers keep pace with regulatory developments that can impact their benefits programs and overall strategy. As the pharmacy benefits landscape continues to evolve, our team is here to help you understand the changes and prepare for what comes next.